Introduction P|ESG Approach Impact Ambitions 35 Social Employee Engagement & Development Inclusive Culture Health & Safety People in our Value Chain Human Rights Introduction P|ESG Approach Impact Ambitions 36 In 2025, we recruited and onboarded more than 300 new employees worldwide, marking another year of significant growth at Ascendis Pharma
Retatrutide, identified by its developmental code LY-3437943, is an investigational medication created by Eli Lilly for treating obesity, overweight conditions, and associated metabolic disorders including type 2 diabetes
Research published in Nutrition Journal confirms ginger reduces nausea through 5-HT3 receptor antagonism, the same pathway used by some anti-nausea medications
Plasma homocysteine concentration predicts mortality in noninsulin-dependent diabetic patients with and without albuminuria
There are many pros and cons to both printable weight loss tracker templates and digital apps for recording weight loss
10.1007/s10557-018-6773-2 84